BioMarin Pharmaceutical Inc. financial reports, BioMarin Pharmaceutical Inc. annual revenue in 2024. When does BioMarin Pharmaceutical Inc. report revenue?
BioMarin Pharmaceutical Inc. total revenue, net income and dynamics of changes in US dollar today
Net revenue of BioMarin Pharmaceutical Inc. on 30/06/2021 amounted to 501 693 000 $. The dynamics of net income of BioMarin Pharmaceutical Inc. has changed by -4 430 000 $ in recent years. These are the main financial indicators of BioMarin Pharmaceutical Inc.. Information on BioMarin Pharmaceutical Inc. net income on the chart on this page is drawn in blue bars. BioMarin Pharmaceutical Inc. total revenue on the graph is shown in yellow. A graph of the value of all BioMarin Pharmaceutical Inc. assets is presented in green bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
501 693 000 $
+29.38 % ↑
12 941 000 $
-
31/03/2021
486 030 000 $
+21.28 % ↑
17 371 000 $
-
31/12/2020
452 117 000 $
+28 % ↑
22 099 000 $
-
30/09/2020
476 784 000 $
+3.4 % ↑
784 803 000 $
+1 325.980 % ↑
30/09/2019
461 097 000 $
-
55 036 000 $
-
30/06/2019
387 763 000 $
-
-37 435 000 $
-
31/03/2019
400 745 000 $
-
-56 473 000 $
-
31/12/2018
353 214 000 $
-
-3 650 000 $
-
30/09/2018
391 706 000 $
-
-12 620 000 $
-
30/06/2018
372 845 000 $
-
-16 792 000 $
-
31/03/2018
373 447 000 $
-
-44 149 000 $
-
31/12/2017
358 305 000 $
-
-51 392 000 $
-
30/09/2017
334 148 000 $
-
-12 527 000 $
-
30/06/2017
317 448 000 $
-
-36 833 000 $
-
Show:
to
BioMarin Pharmaceutical Inc. financial report charts
Dates of BioMarin Pharmaceutical Inc. finance reports: 30/06/2017, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of BioMarin Pharmaceutical Inc. for today is 30/06/2021. Gross profit BioMarin Pharmaceutical Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit BioMarin Pharmaceutical Inc. is 213 524 000 $
BioMarin Pharmaceutical Inc. quarterly report dates
Cost of revenue BioMarin Pharmaceutical Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue BioMarin Pharmaceutical Inc. is 288 169 000 $ Total revenue BioMarin Pharmaceutical Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue BioMarin Pharmaceutical Inc. is 501 693 000 $ Operating income BioMarin Pharmaceutical Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income BioMarin Pharmaceutical Inc. is 13 872 000 $
Net income BioMarin Pharmaceutical Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income BioMarin Pharmaceutical Inc. is 12 941 000 $ Current assets BioMarin Pharmaceutical Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets BioMarin Pharmaceutical Inc. is 2 357 837 000 $ Total assets BioMarin Pharmaceutical Inc. refers to the total amount of assets owned by a person or entity. Total assets BioMarin Pharmaceutical Inc. is 5 898 496 000 $
30/06/2021
31/03/2021
31/12/2020
30/09/2020
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
213 524 000 $
217 139 000 $
169 312 000 $
140 938 000 $
191 185 000 $
124 686 000 $
127 972 000 $
102 805 000 $
151 405 000 $
118 244 000 $
291 114 000 $
282 310 000 $
274 668 000 $
261 143 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
288 169 000 $
268 891 000 $
282 805 000 $
335 846 000 $
269 912 000 $
263 077 000 $
272 773 000 $
250 409 000 $
240 301 000 $
254 601 000 $
82 333 000 $
75 995 000 $
59 480 000 $
56 305 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
501 693 000 $
486 030 000 $
452 117 000 $
476 784 000 $
461 097 000 $
387 763 000 $
400 745 000 $
353 214 000 $
391 706 000 $
372 845 000 $
373 447 000 $
358 305 000 $
334 148 000 $
317 448 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
461 097 000 $
387 763 000 $
400 745 000 $
353 214 000 $
391 706 000 $
372 845 000 $
369 099 000 $
353 577 000 $
298 752 000 $
315 926 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
13 872 000 $
27 341 000 $
-41 692 000 $
-54 041 000 $
4 810 000 $
-49 454 000 $
-41 691 000 $
-68 923 000 $
-4 741 000 $
-42 563 000 $
-44 372 000 $
-66 953 000 $
-13 727 000 $
-38 812 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
12 941 000 $
17 371 000 $
22 099 000 $
784 803 000 $
55 036 000 $
-37 435 000 $
-56 473 000 $
-3 650 000 $
-12 620 000 $
-16 792 000 $
-44 149 000 $
-51 392 000 $
-12 527 000 $
-36 833 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
-
-
-
-
185 641 000 $
185 641 000 $
175 390 000 $
175 390 000 $
175 390 000 $
183 948 000 $
168 608 000 $
154 103 000 $
143 039 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
487 821 000 $
458 689 000 $
493 809 000 $
530 825 000 $
456 287 000 $
437 217 000 $
442 436 000 $
422 137 000 $
396 447 000 $
415 408 000 $
335 486 000 $
349 263 000 $
288 395 000 $
299 955 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
2 357 837 000 $
2 288 766 000 $
2 342 219 000 $
2 738 979 000 $
1 859 359 000 $
1 806 768 000 $
1 916 855 000 $
2 056 215 000 $
2 407 853 000 $
2 280 067 000 $
2 241 110 000 $
2 207 144 000 $
2 050 029 000 $
1 458 820 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
5 898 496 000 $
5 805 053 000 $
5 848 020 000 $
6 158 090 000 $
4 558 128 000 $
4 393 384 000 $
4 435 398 000 $
4 427 128 000 $
4 695 254 000 $
4 624 679 000 $
4 596 717 000 $
4 633 125 000 $
4 580 697 000 $
4 019 965 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
641 533 000 $
667 313 000 $
649 158 000 $
1 015 675 000 $
423 220 000 $
307 577 000 $
364 369 000 $
493 982 000 $
882 184 000 $
427 411 000 $
473 980 000 $
598 028 000 $
431 399 000 $
354 864 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
493 745 000 $
439 428 000 $
500 986 000 $
523 241 000 $
838 660 000 $
804 950 000 $
365 326 000 $
360 949 000 $
-
-
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
-
-
1 382 795 000 $
1 395 968 000 $
1 257 099 000 $
727 776 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
1 483 723 000 $
1 432 430 000 $
1 498 771 000 $
1 459 188 000 $
1 780 309 000 $
1 739 575 000 $
1 182 998 000 $
1 174 470 000 $
-
-
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
32.55 %
32.60 %
33.79 %
32.96 %
37.92 %
37.62 %
25.74 %
25.35 %
-
-
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
4 241 571 000 $
4 162 010 000 $
4 106 002 000 $
4 053 893 000 $
3 074 405 000 $
2 960 954 000 $
2 936 627 000 $
2 967 940 000 $
2 914 945 000 $
2 885 104 000 $
2 807 003 000 $
2 808 663 000 $
2 813 562 000 $
2 795 579 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
70 125 000 $
-24 338 000 $
-54 868 000 $
49 374 000 $
47 200 000 $
-33 857 000 $
-42 509 000 $
14 614 000 $
38 292 000 $
18 780 000 $
Last revenue report of BioMarin Pharmaceutical Inc. was 30/06/2021. According to last financial report total revenue in BioMarin Pharmaceutical Inc. was 501 693 000 US dollar and changed by +29.38% since last year. Net income in BioMarin Pharmaceutical Inc. was 12 941 000 $ in last quartal, net income changes to +1 325.980%.
Current cash BioMarin Pharmaceutical Inc. - the sum of all of the cash a company has on the date of report. Current cash BioMarin Pharmaceutical Inc. is 641 533 000 $
BioMarin Pharmaceutical Inc. stocks data
BMRN stock price
BioMarin Pharmaceutical Inc. stock price today, BMRN stock quote.
